Report / Trial registry metadata
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
A registered study record. Recorded registry status: RECRUITING. A registry entry is not a treatment recommendation or proof that a study succeeded.
Limits
No clinical review has been performed. This record is not a treatment recommendation, eligibility confirmation or current availability guarantee.
- Kind
- Trial registry metadata
- Status
- RECRUITING